RPPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 4.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
4.418800E-01
Normal-vs-Stage2
4.423200E-01
Normal-vs-Stage3
4.254200E-01
Normal-vs-Stage4
4.539200E-01
Stage1-vs-Stage2
9.881000E-01
Stage1-vs-Stage3
4.903800E-01
Stage1-vs-Stage4
7.583400E-01
Stage2-vs-Stage3
4.111600E-01
Stage2-vs-Stage4
9.271000E-01
Stage3-vs-Stage4
4.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
4.264800E-01
Normal-vs-AfricanAmerican
4.313200E-01
Normal-vs-Asian
4.245200E-01
Caucasian-vs-AfricanAmerican
6.533800E-01
Caucasian-vs-Asian
5.786800E-01
AfricanAmerican-vs-Asian
6.367000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
4.279400E-01
Normal-vs-Female
4.606600E-01
Male-vs-Female
3.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
4.183600E-01
Normal-vs-Age(41-60Yrs)
4.261800E-01
Normal-vs-Age(61-80Yrs)
4.540000E-01
Normal-vs-Age(81-100Yrs)
4.232000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.409200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.812570E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.565400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.052000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.394000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
4.214200E-01
Normal-vs-Daily Drinker
4.275200E-01
Normal-vs-Weekly Drinker
4.232600E-01
Normal-vs-Occasional Drinker
4.235200E-01
Normal-vs-Social Drinker
4.308800E-01
Non Drinker-vs-Daily Drinker
1.391040E-01
Non Drinker-vs-Weekly Drinker
6.033600E-01
Non Drinker-vs-Occasional Drinker
5.543400E-01
Non Drinker-vs-Social Drinker
2.891400E-01
Daily Drinker-vs-Weekly Drinker
3.299200E-01
Daily Drinker-vs-Occasional Drinker
4.065400E-01
Daily Drinker-vs-Social Drinker
7.215400E-01
Weekly Drinker-vs-Occasional Drinker
9.456800E-01
Weekly Drinker-vs-Social Drinker
3.933200E-01
Occasional Drinker-vs-Social Drinker
4.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
3.432200E-01
Normal-vs-Grade 2
1.782370E-01
Normal-vs-Grade 3
5.541800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.597800E-01
Grade 1-vs-Grade 3
8.902200E-01
Grade 1-vs-Grade 4
3.432200E-01
Grade 2-vs-Grade 3
3.764600E-01
Grade 2-vs-Grade 4
1.782370E-01
Grade 3-vs-Grade 4
5.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
4.247400E-01
Normal-vs-NonDiabetic
4.508200E-01
Diabetic-vs-NonDiabetic
3.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
4.198000E-01
Normal-vs-NoPancreatitis
4.473800E-01
Pancreatitis-vs-NoPancreatitis
2.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
4.337600E-01
Normal-vs-N1
4.455000E-01
N0-vs-N1
6.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
4.512000E-01
Normal-vs-TP53-NonMutant
3.955600E-01
TP53-Mutant-vs-TP53-NonMutant
2.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap